Company profile
Windward Bio company profile
Windward Bio is a clinical-stage drug development company focused on improving outcomes for individuals with advanced immunological diseases, particularly severe respiratory conditions. The company is advancing a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP) into phase 2 development while creating innovative bispecific programs for various immunological disorders. Led by a team of biopharmaceutical executives, Windward Bio aims to address significant unmet medical needs in this field.
Business identity
- Website
- https://windwardbio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2024-01-01, Year
Headquarters
- Headquarters
- Breíl, Grisons, Switzerland
- Country code
- CH
- Continent
- Europe